Healthcare
Tuesday, January 17, 2017
BRIEF-Protagonist Therapeutics says initiated global phase 2b induction study in ulcerative colitis with PTG-100
* Protagonist therapeutics inc says initiated a global
phase 2b induction study in ulcerative colitis with ptg-100
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment